BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37002241)

  • 1. Identification and characterization of novel ETV4 splice variants in prostate cancer.
    Cosi I; Moccia A; Pescucci C; Munagala U; Di Giorgio S; Sineo I; Conticello SG; Notaro R; De Angioletti M
    Sci Rep; 2023 Mar; 13(1):5267. PubMed ID: 37002241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
    Aytes A; Mitrofanova A; Kinkade CW; Lefebvre C; Lei M; Phelan V; LeKaye HC; Koutcher JA; Cardiff RD; Califano A; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):E3506-15. PubMed ID: 23918374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
    Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
    J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
    Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
    Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
    Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
    Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
    Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
    Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.
    Yao D; Bao Z; Qian X; Yang Y; Mao Z
    Cell Biol Int; 2021 Oct; 45(10):2129-2139. PubMed ID: 34270850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
    Li D; Zhan Y; Wang N; Tang F; Lee CJ; Bayshtok G; Moore AR; Wong EWP; Pachai MR; Xie Y; Sher J; Zhao JL; Khudoynazarova M; Gopalan A; Chan J; Khurana E; Shepherd P; Navone NM; Chi P; Chen Y
    Sci Adv; 2023 Apr; 9(14):eadc9446. PubMed ID: 37018402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
    Gasi D; Trapman J
    Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
    Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN
    Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines.
    Adler D; Ochsenfahrt J; Fuchs K; Wernert N
    Oncol Rep; 2012 May; 27(5):1321-4. PubMed ID: 22307076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2.
    Cheng T; Zhang Z; Cheng Y; Zhang J; Tang J; Tan Z; Liang Z; Chen T; Liu Z; Li J; Zhao J; Zhou R
    Biochem Biophys Res Commun; 2019 Aug; 516(1):278-284. PubMed ID: 31253395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.
    Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
    Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
    Oh S; Shin S; Janknecht R
    Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of ETV4 at Ser73 by ERK kinase could block ETV4 ubiquitination degradation in colorectal cancer.
    Xiao J; Yang S; Shen P; Wang Y; Sun H; Ji F; Zhou D
    Biochem Biophys Res Commun; 2017 May; 486(4):1062-1068. PubMed ID: 28373072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling.
    Wollenick K; Hu J; Kristiansen G; Schraml P; Rehrauer H; Berchner-Pfannschmidt U; Fandrey J; Wenger RH; Stiehl DP
    Nucleic Acids Res; 2012 Mar; 40(5):1928-43. PubMed ID: 22075993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.
    Rodriguez AC; Vahrenkamp JM; Berrett KC; Clark KA; Guillen KP; Scherer SD; Yang CH; Welm BE; Janát-Amsbury MM; Graves BJ; Gertz J
    Cancer Res; 2020 Mar; 80(6):1234-1245. PubMed ID: 32046982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.